SCHEMBL88030

SCHEMBL88030

O=P(=O)OCC(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL6037524 0.97 LMNA (0.45)
SCHEMBL4668090 0.82
SCHEMBL5374083 0.81 LMNA (0.42)
SCHEMBL11392903 0.76
SCHEMBL28472492 0.74
SCHEMBL30631090 0.73 ALDH1A1 (0.35)
SCHEMBL5558849 0.72
SCHEMBL50793 0.70
SCHEMBL680245 0.70
SCHEMBL27390028 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12995 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746853-A1 A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. (DE) 2026-05-27 EP claimed
CN-120530909-B Early breeding and evaluating method for salt tolerance of grass carp based on serum metabolic markers 中国水产科学研究院淡水渔业研究中心 2026-05-19 CN claimed
WO-2025021835-A9 A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-11-06 WO claimed
CN-119630696-A APOE lipoprotein System 基斯比治疗公司 2025-03-14 CN claimed
WO-2025021286-A1 A DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-01-30 WO claimed
WO-2025021835-A1 A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-01-30 WO claimed
CN-118973614-A Lipid nanoparticles for delivery of nucleic acids to spleen tissue and methods of using the same for delivery of nucleic acids to spleen tissue 日油株式会社 2024-11-15 CN claimed
CN-118475683-A Acid-resistant yeast strain for high yield of succinic acid, and construction method and application thereof 中国科学院天津工业生物技术研究所 2024-08-09 CN claimed
CN-118338906-A Composition for treating skin of diabetic patient 米贝尔股份公司 2024-07-12 CN claimed
WO-2024139084-A1 PREPARATION METHOD FOR AND USE OF CLOSTRIDIUM BUTYRICUM MICROCAPSULE 天津博菲德科技有限公司 2024-07-04 WO claimed
US-4753788-A HOMOGENIZING LIPIDS VESTAR RESEARCH INC. (US) 1988-06-28 US claimed
US-4749522-A LIPIDS, PROTEINS, POLYSACCHARIDES, AND NUCLEOTIDES FROM TISSUE; PURIFICATION OR SEPARATION WITH GASES ANGIO-MEDICAL CORPORATION (US) 1988-06-07 US claimed
CN-87104963-A Stable pharmaceutical agent containing granulocyte colony stimulating factor and process for producing the same 1988-02-24 CN claimed
EP-0231973-A2 Textile treating compositions and methods THE PROCTER & GAMBLE COMPANY (US) 1987-08-12 EP claimed
US-4643919-A SATURATED LIPID AND SOFTENING AGENT THE PROCTER & GAMBLE COMPANY (US) 1987-02-17 US claimed
US-4610868-A TIME-RELEASE AGENTS THE LIPOSOME COMPANY, INC. (US) 1986-09-09 US claimed
EP-0190050-A2 Method for preparing small vesicles using microemulsification VESTAR, INC. (US) 1986-08-06 EP claimed
US-4575461-A FREE-FLOWING PARTICLES AMERICAN MAIZE-PRODUCTS COMPANY (US) 1986-03-11 US claimed
US-4551446-A Use of synthetic phosphoglycerides possessing platelet activating properties as desensitizing agents BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1985-11-05 US claimed
US-4542019-A Antacid compositions LEZDEY JOHN 1985-09-17 US claimed